No abstract

Lyme disease and its treatment implications have become an ever-increasing area of concern within the United States related to the markedly increased prevalence of infection within the last two decades. The presentation, pathophysiology, and epidemiology of Lyme disease have been well studied, and thus treatments for this disease are widely available. While the treatment of its early and late stages is relatively simple with 10-14 day and four-week courses of doxycycline, respectively, the main problem rests in the understanding of the etiology and pathology of post-treatment Lyme disease syndrome (PTLDS). With the time of symptoms onsetting approximately six months after treatment and potentially lasting indefinitely, this syndrome's effect on patients' quality of life could be devastating. Searching on PubMed, Google Scholar, MEDLINE, and ScienceDirect using keywords including Lyme disease, PTLDS, doxycycline, erythema migrans, azlocillin, and treatment, the authors have tried to make clear the different aspects. The authors have reviewed and discussed clinical studies of Lyme disease and its treatments/potential therapeutics as well as PTLDS and its sparse treatments/potential therapeutics.

Prior knowledge of possible variantions in human anatomy is essential for basic medical and clinical training. Many surgeons can avoid uncharacteristic situations by having sources and availability of resources that document potential irregularities in human anatomy. In this case, a human cadaver is identified as having an altered origin of the posterior circumflex humeral artery (PCHA). While it usually stems from the axillary artery, this cadaver had a left-sided PCHA originating from the subscapular artery (SSA) and continuing into the quadrangular space. This irregularity of the PCHA from the SSA is not commonly discussed in the literature. Physicians and anatomists need to be fully aware of this possibility and be prepared for any unexpected differences in anatomy during procedures.